Lisa A. Elferink

Affiliations: 
University of Texas Medical Branch, Galveston, TX 
Area:
Molecular Biology, Cell Biology
Google:
"Lisa Elferink"

Children

Sign in to add trainee
David J. Strick grad student 2005 UTMB
Kristin S. Hill grad student 2011 UTMB
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Gaziova I, Jackson D, Boor PJ, et al. (2016) The MET Receptor Tyrosine Kinase Confers Repair of Murine Pancreatic Acinar Cells following Acute and Chronic Injury. Plos One. 11: e0165485
Gaziova I, Davey RA, Elferink LA. (2015) Identification of factors regulating MET receptor endocytosis by high-throughput siRNA screening. Methods in Molecular Biology (Clifton, N.J.). 1270: 381-94
Tao X, Hill KS, Gaziova I, et al. (2014) Silencing Met receptor tyrosine kinase signaling decreased oral tumor growth and increased survival of nude mice. Oral Oncology. 50: 104-12
Garnett J, Chumbalkar V, Vaillant B, et al. (2013) Regulation of HGF expression by ΔEGFR-mediated c-Met activation in glioblastoma cells. Neoplasia (New York, N.Y.). 15: 73-84
Hill KS, Gaziova I, Harrigal L, et al. (2012) Met receptor tyrosine kinase signaling induces secretion of the angiogenic chemokine interleukin-8/CXCL8 in pancreatic cancer. Plos One. 7: e40420
Chen Z, Kolokoltsov AA, Wang J, et al. (2012) GRB2 interaction with the ecotropic murine leukemia virus receptor, mCAT-1, controls virus entry and is stimulated by virus binding. Journal of Virology. 86: 1421-32
Elferink LA, Resto VA. (2011) Receptor-tyrosine-kinase-targeted therapies for head and neck cancer. Journal of Signal Transduction. 2011: 982879
Sastry SK, Elferink LA. (2011) Checks and balances: interplay of RTKs and PTPs in cancer progression. Biochemical Pharmacology. 82: 435-40
Hill KS, Lorinczi M, Elferink LA. (2010) Altered down regulation of the receptor tyrosine kinase met in pancreatic adenocarcinoma cells. Journal of Experimental Therapeutics & Oncology. 8: 297-312
Ying H, Zheng H, Scott K, et al. (2010) Mig-6 controls EGFR trafficking and suppresses gliomagenesis. Proceedings of the National Academy of Sciences of the United States of America. 107: 6912-7
See more...